Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5594
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo ; day:24 ; month:11 ; year:2020 ; pages:1-17
Oncogene ; (24.11.2020), 1-17
- Urheber
-
Attalla, Sherif
Taifour, Tarek
Bui, Tung
Muller, William
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41388-020-01560-0
- URN
-
urn:nbn:de:101:1-2021010420190480453730
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Attalla, Sherif
- Taifour, Tarek
- Bui, Tung
- Muller, William
- SpringerLink (Online service)
Ähnliche Objekte (12)
Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model
PyMT-1099, a versatile murine cell model for EMT in breast cancer
GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer
MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice
Extracellular Proteolysis in Transgenic Mouse Models of Breast Cancer
Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer
Breast cancer
Breast cancer
Breast cancer
Canonical NF-κB signaling in myeloid cells promotes lung metastasis in the PyMT breast cancer model
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer
CYP17genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study
Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model
PyMT-1099, a versatile murine cell model for EMT in breast cancer
GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer
MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice
Extracellular Proteolysis in Transgenic Mouse Models of Breast Cancer
Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer
Breast cancer
Breast cancer
Breast cancer
Canonical NF-κB signaling in myeloid cells promotes lung metastasis in the PyMT breast cancer model
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer
CYP17genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study
Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model
PyMT-1099, a versatile murine cell model for EMT in breast cancer
GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer
MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice
Extracellular Proteolysis in Transgenic Mouse Models of Breast Cancer
Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer
Breast cancer
Breast cancer
Breast cancer
Canonical NF-κB signaling in myeloid cells promotes lung metastasis in the PyMT breast cancer model
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer